[Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
作者信息
Bagliani A, Borri P, Taborelli R
出版信息
Minerva Cardioangiol. 1973 Jun;21(6):439-52.
PMID:4720185
Abstract
摘要
相似文献
1
2
3
[Treatment of primary and secondary Raynaud's syndrome using naftidrofuryl (Dusodril)].使用萘呋胺酯（杜手足血管舒）治疗原发性和继发性雷诺综合征
Dtsch Med J. 1971 Dec;22(23):743-5.
4
[The vasoactivogram in the treatment of peripheral arteriopathies].
Angiologia. 1975 Jan-Feb;27(1):7-25.
5
[Clinical use of thymoxamine in peripheral arterial pathology].[百里胺在外周动脉疾病中的临床应用]
Clin Ter. 1983 Apr 30;105(2):103-7.
6
[Effect of surheme on improved blood flow in limbs].
Wiad Lek. 1972 Jul 15;25(14):1297-300.
7
[Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
Minerva Cardioangiol. 1965 Sep;13(9):585-91.
8
[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Minerva Cardioangiol. 1973 Nov;21(11):715-31.
9
[Clinical experiences with naftidrofuryl in peripheral arterial occlusive diseases].[奈呋胺酯治疗周围动脉闭塞性疾病的临床经验]
Med Welt. 1973 Oct 26;24(43):1665-6.
10
[Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)].[萘呋胺酯（都可喜）口服治疗期间小腿血液循环的变化]
Munch Med Wochenschr. 1973 Mar 23;115(12):508-10.
Zotero 插件